829 related articles for article (PubMed ID: 28807037)
1. Selepressin, a novel selective vasopressin V
Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
[TBL] [Abstract][Full Text] [Related]
2. A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock.
He X; Su F; Taccone FS; Laporte R; Kjølbye AL; Zhang J; Xie K; Moussa MD; Reinheimer TM; Vincent JL
Crit Care Med; 2016 Jan; 44(1):23-31. PubMed ID: 26496451
[TBL] [Abstract][Full Text] [Related]
3. Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial.
Laterre PF; Berry SM; Blemings A; Carlsen JE; François B; Graves T; Jacobsen K; Lewis RJ; Opal SM; Perner A; Pickkers P; Russell JA; Windeløv NA; Yealy DM; Asfar P; Bestle MH; Muller G; Bruel C; Brulé N; Decruyenaere J; Dive AM; Dugernier T; Krell K; Lefrant JY; Megarbane B; Mercier E; Mira JP; Quenot JP; Rasmussen BS; Thorsen-Meyer HC; Vander Laenen M; Vang ML; Vignon P; Vinatier I; Wichmann S; Wittebole X; Kjølbye AL; Angus DC;
JAMA; 2019 Oct; 322(15):1476-1485. PubMed ID: 31577035
[TBL] [Abstract][Full Text] [Related]
4. Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical Trial.
Lewis RJ; Angus DC; Laterre PF; Kjølbye AL; van der Meulen E; Blemings A; Graves T; Russell JA; Carlsen JE; Jacobsen K; Yealy DM; Opal SM; Windeløv NA; François B; Perner A; Pickkers P; Berry SM
Ann Am Thorac Soc; 2018 Feb; 15(2):250-257. PubMed ID: 29388815
[TBL] [Abstract][Full Text] [Related]
5. The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock.
Saad AF; Maybauer MO
J Crit Care; 2017 Aug; 40():41-45. PubMed ID: 28319910
[TBL] [Abstract][Full Text] [Related]
6. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
Gordon AC; Mason AJ; Thirunavukkarasu N; Perkins GD; Cecconi M; Cepkova M; Pogson DG; Aya HD; Anjum A; Frazier GJ; Santhakumaran S; Ashby D; Brett SJ;
JAMA; 2016 Aug; 316(5):509-18. PubMed ID: 27483065
[TBL] [Abstract][Full Text] [Related]
7. Vasopressin versus norepinephrine infusion in patients with septic shock.
Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
[TBL] [Abstract][Full Text] [Related]
8. Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock.
Morelli A; Donati A; Ertmer C; Rehberg S; Kampmeier T; Orecchioni A; Di Russo A; D'Egidio A; Landoni G; Lombrano MR; Botticelli L; Valentini A; Zangrillo A; Pietropaoli P; Westphal M
Crit Care; 2011; 15(5):R217. PubMed ID: 21929764
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of short-term vasopressin infusion during severe septic shock.
Patel BM; Chittock DR; Russell JA; Walley KR
Anesthesiology; 2002 Mar; 96(3):576-82. PubMed ID: 11873030
[TBL] [Abstract][Full Text] [Related]
10. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Cecchini V; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
Crit Care; 2009; 13(4):R130. PubMed ID: 19664253
[TBL] [Abstract][Full Text] [Related]
11. Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock.
Hammond DA; Ficek OA; Painter JT; McCain K; Cullen J; Brotherton AL; Kakkera K; Chopra D; Meena N
Pharmacotherapy; 2018 May; 38(5):531-538. PubMed ID: 29600824
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial.
Hajjar LA; Zambolim C; Belletti A; de Almeida JP; Gordon AC; Oliveira G; Park CHL; Fukushima JT; Rizk SI; Szeles TF; Dos Santos Neto NC; Filho RK; Galas FRBG; Landoni G
Crit Care Med; 2019 Dec; 47(12):1743-1750. PubMed ID: 31609774
[TBL] [Abstract][Full Text] [Related]
13. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
[TBL] [Abstract][Full Text] [Related]
14. The selective vasopressin type 1a receptor agonist selepressin (FE 202158) blocks vascular leak in ovine severe sepsis*.
Maybauer MO; Maybauer DM; Enkhbaatar P; Laporte R; Wiśniewska H; Traber LD; Lin C; Fan J; Hawkins HK; Cox RA; Wiśniewski K; Schteingart CD; Landry DW; Rivière PJ; Traber DL
Crit Care Med; 2014 Jul; 42(7):e525-e533. PubMed ID: 24674922
[TBL] [Abstract][Full Text] [Related]
15. Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial.
Permpikul C; Tongyoo S; Viarasilpa T; Trainarongsakul T; Chakorn T; Udompanturak S
Am J Respir Crit Care Med; 2019 May; 199(9):1097-1105. PubMed ID: 30704260
[No Abstract] [Full Text] [Related]
16. Selepressin in Septic Shock: A Step Toward Decatecholaminization?
Asfar P; Russell JA; Tuckermann J; Radermacher P
Crit Care Med; 2016 Jan; 44(1):234-6. PubMed ID: 26672929
[No Abstract] [Full Text] [Related]
17. Selepressin in Septic Shock.
Antonucci E; Giovini M; Agosta S; Sakr Y; Leone M
Shock; 2022 Jun; 57(6):172-179. PubMed ID: 35759300
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
Bissell BD; Magee C; Moran P; Bastin MLT; Flannery AH
J Intensive Care Med; 2019 Sep; 34(9):761-765. PubMed ID: 28750598
[TBL] [Abstract][Full Text] [Related]
19. Low-dose vasopressin in the treatment of vasodilatory septic shock.
Malay MB; Ashton RC; Landry DW; Townsend RN
J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
[TBL] [Abstract][Full Text] [Related]
20. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
